| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |